The rating assignment was supported by a number of factors, including Barnabas’ growing liquidity. As of Sept. 30, the system had unrestricted cash and investments of $1.14 billion, or 159.5 days cash on hand.
The rating assignment was also supported by Barnabas’ considerable market presence, strong margins and acquisition of the Jersey City (N.J.) Medical Center.
Fitch analysts expect Barnabas Health to use the expected increase in cash flow to continue to grow liquidity and strengthen its balance sheet metrics. Additionally, Fitch predicts the system will have to implement its strong management practices to the Jersey City Medical Center to grow profitability.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.